Journey Medical Corporation
DERM
$5.33
$0.020.38%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -114.24% | 59.81% | -3.02% | 79.86% | 266.56% |
| Total Depreciation and Amortization | 0.12% | -23.03% | -23.37% | -32.85% | -19.54% |
| Total Amortization of Deferred Charges | 50.00% | -77.06% | 264.71% | -87.50% | 241.18% |
| Total Other Non-Cash Items | 81.62% | -59.93% | 62.30% | -74.69% | -61.45% |
| Change in Net Operating Assets | -313.38% | -170.67% | -56.78% | -526.68% | 756.25% |
| Cash from Operations | -106.17% | -230.41% | -425.00% | -330.66% | 357.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 200.00% | -100.00% |
| Total Debt Repaid | 94.32% | -- | -- | 90.62% | -1,000.00% |
| Issuance of Common Stock | 1,631.82% | 933.33% | -- | -- | -29.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.32% | 138.44% | 3,048.08% | 1,926.37% | -372.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.68% | 98.41% | 42.72% | 193.14% | 338.97% |
